CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
Dhammapoj Jeerakornpassawat, Prapaporn Suprasert
Obstet Gynecol Sci. 2020;63(1):55-63.   Published online December 23, 2019
DOI: https://doi.org/10.5468/ogs.2020.63.1.55

Excel Download

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
Obstetrics & Gynecology Science. 2020;63(1):55   Crossref logo
Link1 Link2 Link3

Safety and Outcome of Patients Treated with a Modified Outpatient Intraperitoneal Regimen for Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Chemotherapy. 2013;59(4):251-259   Crossref logo
Link1 Link2

908 POSTER A Randomised phase II study of phenoxodiol with platinum or taxane chemotherapy in chemoresistant epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer
European Journal of Cancer Supplements. 2005;3(2):261   Crossref logo
Link1 Link2

Budget Impact of Niraparib As Maintenance Treatment for Medicare Patients with Recurrent Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer Who are in Complete or Partial Response to Platinum-Based Chemotherapy
Value in Health. 2018;21:S21   Crossref logo
Link1 Link2

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Yearbook of Medicine. 2012;2012:138-139   Crossref logo
Link1 Link2

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Yearbook of Oncology. 2012;2012:113-114   Crossref logo
Link1 Link2

Efficacy of second line chemotherapeutic regimens in persistent or recurrent epithelial ovarian cancer including fallopian tube cancer and primary peritoneal cancer: A multicenter retrospective study
Gynecologic Oncology. 2019;154:235-236   Crossref logo
Link1 Link2

Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
Cancer Chemotherapy and Pharmacology. 2019;83(4):717-726   Crossref logo
Link1 Link2 Link3

Evaluation of pemetrexed in the treatment of epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: a retrospective study
. 2020;   Crossref logo
Link1 Link2

Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
Best Practice & Research Clinical Obstetrics & Gynaecology. 2017;41:126-138   Crossref logo
Link1 Link2